Monica Morrow1, Sarah T Hawley2,3,4, M Chandler McLeod5, Ann S Hamilton6, Kevin C Ward7, Steven J Katz2,3, Reshma Jagsi8. 1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. morrowm@mskcc.org. 2. Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, MI, USA. 3. Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, USA. 4. Veterans Administration Center for Clinical Management Research, Ann Arbor VA Health Care System, Ann Arbor, MI, USA. 5. Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA. 6. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. 7. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. 8. Department of Radiation Oncology, School of Medicine, University of Michigan, Ann Arbor, MI, USA.
Abstract
BACKGROUND: Usage of magnetic resonance imaging (MRI) in newly diagnosed breast cancer patients is increasing, despite scant evidence that it improves outcomes. Little is known about the knowledge, perspectives, and clinical characteristics of surgeons associated with MRI use. METHODS: Women with early-stage breast cancer undergoing definitive surgery between July 2013 and August 2015 were identified from the Los Angeles and Georgia Surveillance, Epidemiology and End Results (SEER) registries and were asked to name their attending surgeons. The 489 surgeons were sent a questionnaire; 77% (n = 377) responded. Questions that addressed the likelihood of ordering an MRI in different scenarios were used to create a scale to measure surgeon propensity for MRI use. Knowledge and practice characteristics also were assessed. RESULTS: Mean surgeon age was 54 years, 25% were female, and median number of years in practice was 21. Wide MRI use variation was observed, with 26% obtaining MRI for a clinical stage I screen-detected breast cancer and 72% for infiltrating lobular cancer. High users of MRI were significantly more likely to be higher-volume surgeons (p < 0.001) and to have misconceptions about MRI benefits (p < 0.001). Of surgeons who felt they used MRI more often, 60% were high MRI users; only 6% were low MRI users. CONCLUSIONS: Our findings suggest relatively frequent use of MRI, even in uncomplicated clinical scenarios, in the absence of evidence of benefit, and use was more common among high-volume surgeons. A substantial number of surgeons who are high MRI users harbor misconceptions about MRI benefit, suggesting an opportunity for education and consensus building regarding appropriate use.
BACKGROUND: Usage of magnetic resonance imaging (MRI) in newly diagnosed breast cancer patients is increasing, despite scant evidence that it improves outcomes. Little is known about the knowledge, perspectives, and clinical characteristics of surgeons associated with MRI use. METHODS: Women with early-stage breast cancer undergoing definitive surgery between July 2013 and August 2015 were identified from the Los Angeles and Georgia Surveillance, Epidemiology and End Results (SEER) registries and were asked to name their attending surgeons. The 489 surgeons were sent a questionnaire; 77% (n = 377) responded. Questions that addressed the likelihood of ordering an MRI in different scenarios were used to create a scale to measure surgeon propensity for MRI use. Knowledge and practice characteristics also were assessed. RESULTS: Mean surgeon age was 54 years, 25% were female, and median number of years in practice was 21. Wide MRI use variation was observed, with 26% obtaining MRI for a clinical stage I screen-detected breast cancer and 72% for infiltrating lobular cancer. High users of MRI were significantly more likely to be higher-volume surgeons (p < 0.001) and to have misconceptions about MRI benefits (p < 0.001). Of surgeons who felt they used MRI more often, 60% were high MRI users; only 6% were low MRI users. CONCLUSIONS: Our findings suggest relatively frequent use of MRI, even in uncomplicated clinical scenarios, in the absence of evidence of benefit, and use was more common among high-volume surgeons. A substantial number of surgeons who are high MRI users harbor misconceptions about MRI benefit, suggesting an opportunity for education and consensus building regarding appropriate use.
Authors: Nehmat Houssami; Robin Turner; Petra Macaskill; Lindsay W Turnbull; David R McCready; Todd M Tuttle; Neha Vapiwala; Lawrence J Solin Journal: J Clin Oncol Date: 2014-01-06 Impact factor: 44.544
Authors: N H G M Peters; S van Esser; M A A J van den Bosch; R K Storm; P W Plaisier; T van Dalen; S C E Diepstraten; T Weits; P J Westenend; G Stapper; M A Fernandez-Gallardo; I H M Borel Rinkes; R van Hillegersberg; W P Th M Mali; P H M Peeters Journal: Eur J Cancer Date: 2010-12-30 Impact factor: 9.162
Authors: J Heil; A Buehler; M Golatta; J Rom; A Schipp; A Harcos; A Schneeweiss; G Rauch; C Sohn; H Junkermann Journal: Ann Oncol Date: 2011-04-02 Impact factor: 32.976
Authors: Jeffrey Q Cao; Pauline T Truong; Ivo A Olivotto; Robert Olson; Genevieve Coulombe; Mira Keyes; Lorna Weir; Karen Gelmon; Vanessa Bernstein; Ryan Woods; Caroline Speers; Scott Tyldesley Journal: Int J Radiat Oncol Biol Phys Date: 2014-09-03 Impact factor: 7.038
Authors: Alice K Fortune-Greeley; Stephanie B Wheeler; Anne-Marie Meyer; Katherine E Reeder-Hayes; Andrea K Biddle; Hyman B Muss; William R Carpenter Journal: Breast Cancer Res Treat Date: 2013-12-04 Impact factor: 4.872
Authors: Karen J Wernli; Wendy B DeMartini; Laura Ichikawa; Constance D Lehman; Tracy Onega; Karla Kerlikowske; Louise M Henderson; Berta M Geller; Mike Hofmann; Bonnie C Yankaskas Journal: JAMA Intern Med Date: 2014-01 Impact factor: 21.873
Authors: Tracy Onega; Anna N A Tosteson; Julie Weiss; Jennifer Alford-Teaster; Rebecca A Hubbard; Louise M Henderson; Karla Kerlikowske; Martha E Goodrich; Cristina O'Donoghue; Karen J Wernli; Wendy B DeMartini; Beth A Virnig Journal: BMC Health Serv Res Date: 2016-02-27 Impact factor: 2.655
Authors: Santo Maimone; Andrey P Morozov; Zhuo Li; Emily C Craver; Erin A Elder; Sarah A McLaughlin Journal: Ann Surg Oncol Date: 2022-03-08 Impact factor: 5.344